31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
NEW GUIDANCE ON PUBLIC HEARINGS ON HOUSING PROPOSALS - The Massachusetts Department of Housing & C...
Read More >
EB-1 immigration lawyers at Klasko Immigration Law Partners, LLP have been helping foreign individua...
Read More >
The U.S. Department of Homeland Security (DHS) has finalized plans to charge employers a $10 registr...
Read More >
Given the recent tropical systems that have hit Texas including Laura and Beta (who still has not de...
Read More >
PRO Act to Hit the Floor. The “Protecting the Right to Organize Act of 2019” (H.R. 2474) is headed...
Read More >
On January 6, 2020, Governor Ned Lamont signed bipartisan legislation addressing rates of pay for re...
Read More >